LU-ATMP: Lund University Advanced Therapy Medicinal Products
1 – 10 of 18
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2026
-
Mark
Population-level genomic analysis of immunoglobulin loci variation in rhesus macaques reveals extensive germline diversity
- Contribution to journal › Article
-
Mark
The TransEuro open-label trial of human fetal ventral mesencephalic transplantation in patients with moderate Parkinson's disease
- Contribution to journal › Article
-
Mark
AI-driven Quality Control of cell-based ATMPs: Automated, Accurate, and Affordable
(2026) In Cytotherapy
- Contribution to journal › Article
-
Mark
Toward standardized iPSC testing: Insights from a multi-year international Quality Assessment Round
- Contribution to journal › Article
-
Mark
An optimized protocol for efficient derivation of pancreatic islets from multiple human pluripotent stem cell lines
- Contribution to journal › Article
- 2025
-
Mark
Bi-allelic NRXN1α deletion in microglia derived from iPSC of an autistic patient increases interleukin-6 production and impairs supporting function on neuronal networking
- Contribution to journal › Article
-
Mark
Defined culture conditions robustly maintain human stem cell pluripotency, highlighting a role for Ca2+ signaling
- Contribution to journal › Article
-
Mark
Editorial : Allergen-specific antibodies: from basic science to clinical application
- Contribution to journal › Debate/Note/Editorial
-
Mark
Aberrant expression of SLAMF6 constitutes a targetable immune escape mechanism in acute myeloid leukemia
- Contribution to journal › Article
-
Mark
Differentiation of Human Induced Pluripotent Stem Cells Toward Implantable Chondroprogenitor Cells
(2025) In Cartilage
- Contribution to journal › Article
